SCHEMBL10736601

SCHEMBL10736601

O=C1C[C@H](O)C[C@@H](CCCc2ccccc2)O1

nearest known ligand 0.60

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 2/20 0.49
PRKCD Q05655 2/20 0.49
PRKCG P05129 1/20 0.46
PRKCB P05771 1/20 0.46
PRKCH P24723 1/20 0.46
PRKCE Q02156 1/20 0.46
PRKCQ Q04759 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10736619 1.00 PRKCA (0.49) PRKCAPRKCDPRKCGPRKCBPRKCH
SCHEMBL10736607 1.00 PRKCA (0.49) PRKCAPRKCDPRKCGPRKCBPRKCH
SCHEMBL7757693 0.91
SCHEMBL7401650 0.79 GRM2 (0.42) PRKCAPRKCD
SCHEMBL7401646 0.79 GRM2 (0.42) PRKCAPRKCD
SCHEMBL11356361 0.79 SSTR2 (0.44)
SCHEMBL7401654 0.79 GRM2 (0.42) PRKCAPRKCD
SCHEMBL7405668 0.79 GRM2 (0.42) PRKCAPRKCD
SCHEMBL7405665 0.79 GRM2 (0.42) PRKCAPRKCD
SCHEMBL7397347 0.78 PRKCA (0.40) PRKCAPRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4710513-A Substituted pyranone inhibitors of cholesterol synthesis MERCK & CO., INC. (US) 1987-12-01 US disclosed
US-4567289-A ANTICHOLESTEROL ANTILIPEMIC MERCK & CO., INC. (US) 1986-01-28 US disclosed
US-4459422-A Substituted pyranone inhibitors of cholesterol synthesis MERCK & CO., INC. (US) 1984-07-10 US disclosed
US-4375475-A ANTICHOLESTEROL AGENTS MERCK & CO., INC. (US) 1983-03-01 US disclosed
EP-0024348-A1 Substituted 6-Phenethyl-and phenylethenyl-3,4,5,6-tetrahydro-4-hydroxytetraydropyran-2-ones in the4-R trans stereoisomeric forms and the corresponding dihydroxy acids, process for preparing and pharmaceutical composition comprising them MERCK & CO. INC. (US) 1981-03-04 EP disclosed